SCHEMBL15519474

SCHEMBL15519474

CC#CCn1c(Br)nc2[nH]c(=O)n(C)c(=O)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.40
ALDH1A1 P00352 4/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPK1 P28482 2/20 0.37
APAF1 O14727 1/20 0.35
CASP6 P55212 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
USP2 O75604 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
RECQL P46063 1/20 0.34
MDM2 Q00987 1/20 0.34
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL497538 0.78 KDM4E (0.62) ALDH1A1MAPTLMNAKDM4EMAPK1
SCHEMBL27908390 0.78 NOD1 (0.37) DPP4ALDH1A1MAPTLMNAKDM4E
SCHEMBL17636795 0.77 SMN1; SMN2 (0.43) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL25522516 0.77 KDM4E (0.47) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL2956851 0.72 ALDH1A1 (0.59) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL27944320 0.71 DPP4 (0.69) DPP4
SCHEMBL21703611 0.70 KDM4E (0.43) DPP4ALDH1A1KDM4ESMN1; SMN2
Trifluoroacetic Acid SCHEMBL5719146 0.70 DPP4 (0.57) DPP4
SCHEMBL2952546 0.69 DPP4 (0.45) DPP4GAA
SCHEMBL15519472 0.68 KDM4E (0.38) DPP4ALDH1A1MAPTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885302-B1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2018-03-07 EP disclosed
US-9593119-B2 Process for the preparation of dipeptidylpeptidase inhibitors GLENMARK PHARMACEUTICALS LIMITED (IN) 2017-03-14 US disclosed
US-20160272642-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK LIFE SCIENCES LIMITED (IN) 2016-09-22 US disclosed
US-9353114-B2 Process for the preparation of dipeptidylpeptidase inhibitors GLENMARK PHARMACEUTICALS LIMITED (IN) 2016-05-31 US disclosed
US-20150239887-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK GENERICS LIMITED (IN) 2015-08-27 US disclosed
EP-2885302-A2 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2015-06-24 EP disclosed
WO-2014033746-A2 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS GLENMARK PHARMACEUTICALS LIMITED; GLENMARK GENERICS LIMITED (IN) 2014-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239887-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS DPP4, DPP9, DPP3 DPP4 1/4885ALDH1A1 590/4885MAPT 3749/4885
US-20160272642-A1 PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS DPP9, DPP4, DPP7 DPP4 2/4885ALDH1A1 681/4885MAPT 3848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.